2016年10月
Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages
SCIENTIFIC REPORTS
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 6
- 号
- 開始ページ
- 35014
- 終了ページ
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1038/srep35014
- 出版者・発行元
- NATURE PUBLISHING GROUP
Lipocalin 2 (Lcn2), also called neutrophil gelatinase B-associated lipocalin (NGAL), is an anti-microbial peptide originally identified in neutrophil granules. Although Lcn2/NGAL expression is increased in the inflamed intestinal tissues of patients with inflammatory bowel disease, the role of Lcn2/NGAL in the development of intestinal inflammation remains unclear. Here we investigated the role of Lcn2/NGAL in intestinal inflammation using a spontaneous mouse colitis model, interleukin-10 knock out (IL-10 KO) mice. Lcn2 expression in the colonic tissues of IL-10 KO mice increased with the development of colitis. Lcn2/IL-10 double-KO mice showed a more rapid onset and development of colitis compared to IL-10 KO mice. Lcn2 enhanced phagocytic bacterial clearance in macrophages in vitro after infection with Escherichia coli. Transfer of Lcn2-repleted macrophages prevented the development of colitis in Lcn2/IL-10 double-KO mice in vivo. Our findings revealed that Lcn2 prevents the development of intestinal inflammation. One crucial factor seems to be the enhancement of phagocytic bacterial clearance in macrophages by Lcn2.
- リンク情報
- ID情報
-
- DOI : 10.1038/srep35014
- ISSN : 2045-2322
- PubMed ID : 27734904
- Web of Science ID : WOS:000385534900001